Market
Scenario
Smoking cessation and nicotine de-addiction are drugs and therapies used in the treatment of withdrawal symptoms associated with the cessation of nicotine. According to the World Health Organization tobacco kills around 6 million people each year and of these almost 5 million deaths are the result of direct tobacco use and approximately 600,000 are the result of passive smoking. Tobacco also derives its users of income, raises healthcare cost and hinder economic development.
Smoking cessation and nicotine de-addiction are drugs and therapies used in the treatment of withdrawal symptoms associated with the cessation of nicotine. According to the World Health Organization tobacco kills around 6 million people each year and of these almost 5 million deaths are the result of direct tobacco use and approximately 600,000 are the result of passive smoking. Tobacco also derives its users of income, raises healthcare cost and hinder economic development.
Nicotine use also is a risk factor for many
diseases and disorders such as cardiovascular diseases, cancer etc. Green
tobacco sickness, caused by nicotine absorption through the skin by the
handling of wet tobacco leaves in tobacco industry is also a concern especially
among children. Tobacco quitting assistance in the form of national cessation
services with cost-coverage are available in only 24 countries, representing
15% of the world's population. Only 42 countries, representing 19% of the
world's population, have instituted advertisement regulations such as pictorial
warnings.
The other market driving factors include
increasing desire and drives to quit smoking and active role of social and
health organizations against tobacco use, the prohibitive costs due to high
taxes leveraged on tobacco products, social stigma imposed on tobacco users
etc. The other critical market driving factor is the huge number of unmet
needs. The World Health Organization (WHO), estimates around 1,100 million
smokers worldwide with emerging economies accounting for around 70% of the
global smoker population.
The market trends include development of
better products such as nicotine gums and patches, e-cigarette’s etc.
The market for Middle East and Africa
smoking cessation and nicotine de-addiction was estimated to be around $ 1040
million in 2016. Taking all factors into consideration, we expect the Middle
East and Africa smoking cessation and nicotine de-addiction market to reach
around $ 2108.38 million, by 2022 growing at a CAGR of 12.5%.
Key
Players of Middle East and Africa Smoking Cessation and Nicotine
De-Addiction Market
Some of the key players in this market are Pfizer Inc, VMR Products LLC, Johnson & Johnson, Novartis International AG, Cipla Inc., and GlaxoSmithKline plc. Nicotek LLC., and Lorillard, Inc. and others.
Segments:
Middle East and Africa smoking cessation and nicotine de-addiction products market has been segmented on the basis of treatment which comprises of pharmacological, therapies etc. On the basis of product type; market is segmented into drugs, inhalers, patches, sprays and gums and others. On the basis of distribution channels; market is segmented into pharmacies, online and de-addiction centers.
Regional Analysis of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market
UAE is the largest market in the entire Middle East and Africa smoking cessation and nicotine de-addiction products market closely followed by Egypt. Algeria and South Africa followed by Ethiopia are fastest growing markets in Africa. The rest of Africa market however has maximum population with unmet medical needs.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2737
Some of the key players in this market are Pfizer Inc, VMR Products LLC, Johnson & Johnson, Novartis International AG, Cipla Inc., and GlaxoSmithKline plc. Nicotek LLC., and Lorillard, Inc. and others.
Segments:
Middle East and Africa smoking cessation and nicotine de-addiction products market has been segmented on the basis of treatment which comprises of pharmacological, therapies etc. On the basis of product type; market is segmented into drugs, inhalers, patches, sprays and gums and others. On the basis of distribution channels; market is segmented into pharmacies, online and de-addiction centers.
Regional Analysis of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market
UAE is the largest market in the entire Middle East and Africa smoking cessation and nicotine de-addiction products market closely followed by Egypt. Algeria and South Africa followed by Ethiopia are fastest growing markets in Africa. The rest of Africa market however has maximum population with unmet medical needs.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2737
Table
Of Content
1.
Report Prologue
2.
Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3.
Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4.
Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5.
Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment